Mental health services around the world are stretched thinner than ever. Long wait times, barriers to accessing care and rising rates of depression and anxiety have made it harder for people to get timely help.
As a result, governments and health care providers are looking for new ways to address this problem. One emerging solution is the use of AI chatbots for mental health care.
A recent study explored whether a new type of AI chatbot, named Therabot, could treat people with mental illness effectively. The findings were promising: not only did participants with clinically significant symptoms of depression and anxiety benefit, those at high-risk for eating disorders also showed improvement. While early, this study may represent a pivotal moment in the integration of AI into mental health care.
AI mental health chatbots are not new—tools like Woebot and Wysa have already been released to the public and studied for years. These platforms follow rules based on a user’s input to produce a predefined approved response.
What makes Therabot different is that it uses generative AI—a technique where a program learns from existing data to create new content in response to a prompt. Consequently, Therabot can produce novel responses based on a user’s input like other popular chatbots such as ChatGPT, allowing for a more dynamic and personalized interaction.
This isn’t the first time generative AI has been examined in a mental health setting. In 2024, researchers in Portugal conducted a study where ChatGPT was offered as an additional component of treatment for psychiatric inpatients.
The research findings showed that just three to six sessions with ChatGPT led to a significantly greater improvement in quality of life than standard therapy, medication and other supportive treatments alone.
Together, these studies suggest that both general and specialized generative AI chatbots hold real potential for use in psychiatric care. But there are some serious limitations to keep in mind. For example, the ChatGPT study involved only 12 participants—far too few to draw firm conclusions.
In the Therabot study, participants were recruited through a Meta Ads campaign, likely skewing the sample toward tech-savvy people who may already be open to using AI. This could have inflated the chatbot’s effectiveness and engagement levels.
Ethics and Exclusion
Beyond methodological concerns, there are critical safety and ethical issues to address. One of the most pressing is whether generative AI could worsen symptoms in people with severe mental illnesses, particularly psychosis.
A 2023 article warned that generative AI’s lifelike responses, combined with most people’s limited understanding of how these systems work, might feed into delusional thinking. Perhaps for this reason, both the Therabot and ChatGPT studies excluded participants with psychotic symptoms.
But excluding these people also raises questions of equity. People with severe mental illness often face cognitive challenges—such as disorganized thinking or poor attention—that might make it difficult to engage with digital tools.
Ironically, these are the people who may benefit the most from accessible, innovative interventions. If generative AI tools are only suitable for people with strong communication skills and high digital literacy, then their usefulness in clinical populations may be limited.
There’s also the possibility of AI “hallucinations”—a known flaw that occurs when a chatbot confidently makes things up—like inventing a source, quoting a nonexistent study, or giving an incorrect explanation. In the context of mental health, AI hallucinations aren’t just inconvenient, they can be dangerous.
That’s what makes these early findings both exciting and cautionary. Yes, AI chatbots might offer a low-cost way to support more people at once, but only if we fully address their limitations.
Effective implementation will require more robust research with larger and more diverse populations, greater transparency about how models are trained and constant human oversight to ensure safety. Regulators must also step in to guide the ethical use of AI in clinical settings.
With careful, patient-centered research and strong guardrails in place, generative AI could become a valuable ally in addressing the global mental health crisis—but only if we move forward responsibly.
News
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
